Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 349

1.

Important cutaneous manifestations of inflammatory bowel disease.

Trost LB, McDonnell JK.

Postgrad Med J. 2005 Sep;81(959):580-5. Review.

2.

Treatment of pyoderma gangrenosum, erythema nodosum, and aphthous ulcerations.

Winter HS.

Inflamm Bowel Dis. 1998 Feb;4(1):71. No abstract available.

PMID:
9552232
3.

[Cutaneous and mucosal manifestations of inflammatory bowel diseases].

Károlyi Z, Erós N, Ujszászy L, Nagy G.

Orv Hetil. 2000 Jun 18;141(25):1391-5. Review. Hungarian.

PMID:
10934882
4.
5.

Treatment of extraintestinal manifestations of inflammatory bowel disease.

Grand RJ.

Inflamm Bowel Dis. 1998 Feb;4(1):72; discussion 73. No abstract available.

PMID:
9552233
6.

Treatment of erythema nodosum, aphthous stomatitis, and pyoderma gangrenosum in patients with IBD.

Tremaine WJ.

Inflamm Bowel Dis. 1998 Feb;4(1):68-9; discussion 73. No abstract available.

PMID:
9552230
7.

Dermatologic manifestations in inflammatory bowel disease in Tunisia.

Mebazaa A, Aounallah A, Naija N, Cheikh Rouhou R, Kallel L, El Euch D, Boubaker J, Mokni M, Filali A, Ben Osman A.

Tunis Med. 2012 Mar;90(3):252-7.

PMID:
22481199
8.

The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.

Bernstein CN, Blanchard JF, Rawsthorne P, Yu N.

Am J Gastroenterol. 2001 Apr;96(4):1116-22.

PMID:
11316157
9.

Do extraintestinal manifestations predict disease course, severity, and/or activity in IBD?

Walker D, Orchard T.

Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S200-1. doi: 10.1002/ibd.20637. No abstract available. Erratum in: Inflamm Bowel Dis. 2009 Sep;15(9):1438-47.

PMID:
18816647
10.

Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.

Regueiro M, Valentine J, Plevy S, Fleisher MR, Lichtenstein GR.

Am J Gastroenterol. 2003 Aug;98(8):1821-6.

PMID:
12907338
11.

Cutaneous manifestations in 404 Iranian patients with inflammatory bowel disease: a retrospective study.

Moravvej H, Razavi GM, Farshchian M, Malekzadeh R.

Indian J Dermatol Venereol Leprol. 2008 Nov-Dec;74(6):607-10.

12.

Concomitant occurrence of pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease.

Goldberg I, Finkel O, Gat A, Sprecher E, de Morentin HM.

Isr Med Assoc J. 2014 Mar;16(3):168-70.

13.

How do I treat erythema nodosum, aphthous ulcerations, and pyoderma gangrenosum?

Hanauer SB.

Inflamm Bowel Dis. 1998 Feb;4(1):70; discussion 73. No abstract available.

PMID:
9552231
14.

Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients.

Farhi D, Cosnes J, Zizi N, Chosidow O, Seksik P, Beaugerie L, Aractingi S, Khosrotehrani K.

Medicine (Baltimore). 2008 Sep;87(5):281-93. doi: 10.1097/MD.0b013e318187cc9c.

15.

Oral manifestations of inflammatory bowel disease: a review based on the observation of six cases.

Lourenço SV, Hussein TP, Bologna SB, Sipahi AM, Nico MM.

J Eur Acad Dermatol Venereol. 2010 Feb;24(2):204-7. doi: 10.1111/j.1468-3083.2009.03304.x. Review.

PMID:
19552719
16.

Cutaneous manifestations in inflammatory bowel disease.

Tromm A, May D, Almus E, Voigt E, Greving I, Schwegler U, Griga T.

Z Gastroenterol. 2001 Feb;39(2):137-44.

PMID:
11253504
17.

Extraintestinal complications of inflammatory bowel disease.

Orchard T.

Curr Gastroenterol Rep. 2003 Dec;5(6):512-7. Review.

PMID:
14602062
18.

Dermatological signs during inflammatory bowel diseases.

Feliciani C, De Simone C, Amerio P.

Eur Rev Med Pharmacol Sci. 2009 Mar;13 Suppl 1:15-21. Review.

PMID:
19530507
19.

Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort.

Vavricka SR, Rogler G, Gantenbein C, Spoerri M, Prinz Vavricka M, Navarini AA, French LE, Safroneeva E, Fournier N, Straumann A, Froehlich F, Fried M, Michetti P, Seibold F, Lakatos PL, Peyrin-Biroulet L, Schoepfer AM.

Inflamm Bowel Dis. 2015 Aug;21(8):1794-800. doi: 10.1097/MIB.0000000000000429.

PMID:
26020601
20.

Neutrophilic dermatoses: a review of current treatment options.

Cohen PR.

Am J Clin Dermatol. 2009;10(5):301-12. doi: 10.2165/11310730-000000000-00000. Review.

PMID:
19658442
Items per page

Supplemental Content

Support Center